EAST LANSING, Mich. -- If a disease affects motoneurons, cells that control voluntary muscle activity, researchers should focus their efforts on motoneurons to find potential treatments, right?
Not always.
In new research led by Michigan State University and published in the current issue of Human Molecular Genetics, scientists have found a new target, which could lead to future treatments for Kennedy's disease. The disease, also known as spinal bulbar muscular atrophy, affects only men later in life and robs them of the capacity to walk, run, chew and swallow.